Vision damage from a complication of premature birth can be halted if it’s caught soon enough — and a California Perinatal Quality Care (CPQCC) and Stanford Medicine-led study shows the state’s screening process is helping close racial gaps.
Category: Ophthalmology
Not all about neurons: A new avenue for treating neurodegeneration, injury
Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.
Scientists use video games to measure the eye-brain-body connection
Stanford Medicine researchers have found a way to track vision performance and eye health through video games.
A big jump in prosthetic vision
By devising special pixels, Stanford University researchers have enhanced prosthetic vision with a new implant that improves vision.
New drug gives patient his sight back
A Stanford patient improved greatly after being the first person with sight-threatening thyroid eye disease to receive the drug teprotumumab.
Stanford students design a device to detect early-stage river blindness
A team of Stanford undergraduates designed a device that uses blue-light imaging technology to diagnose a parasitic disease called river blindness.
Investigating disparities in eye cancer treatment
Stanford researchers studied whether there was any pattern linking patients' racial, ethnic or socioeconomic status with which treatment they received.
Macular degeneration steals sight. A chip implant may get it back.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
New Biodesign fellows will focus on vision care
This year, Stanford Biodesign Innovation Fellows will concentrate on ophthalmology, spending 10 months to address needs in that field.